Humoral and cellular immunogenicity to a second dose of COVID-19 vaccine BNT162b2 in people receiving methotrexate or targeted immunosuppression: a longitudinal cohort study
接受甲氨蝶呤或靶向免疫抑制治疗的人群接种第二剂新冠疫苗BNT162b2后的体液和细胞免疫原性:一项纵向队列研究
期刊:Lancet Rheumatology
影响因子:16.4
doi:10.1016/S2665-9913(21)00333-7
Mahil, Satveer K; Bechman, Katie; Raharja, Antony; Domingo-Vila, Clara; Baudry, David; Brown, Matthew A; Cope, Andrew P; Dasandi, Tejus; Graham, Carl; Khan, Hataf; Lechmere, Thomas; Malim, Michael H; Meynell, Freya; Pollock, Emily; Sychowska, Kamila; Barker, Jonathan N; Norton, Sam; Galloway, James B; Doores, Katie J; Tree, Timothy; Smith, Catherine H